CARL ZEISS MEDITEC ADR 1 Cash Flow Quality Index
CARL ZEISS MEDITEC ADR 1 cash flow quality index. CARL ZEISS MEDITEC ADR 1 (AFXA) has a Cash Flow Quality Index of 2.78x as of September 2025. Operating cash flow of €144.16 Million exceeds net income of €51.81 Million, indicating high earnings quality where cash backs reported profits. Explore CARL ZEISS MEDITEC ADR 1 debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of CARL ZEISS MEDITEC ADR 1 (2022–2025)
Cash flow quality index of CARL ZEISS MEDITEC ADR 1 from 2022 to 2025. Historical Cash Flow Quality Index for CARL ZEISS MEDITEC ADR 1 across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. See CARL ZEISS MEDITEC ADR 1 balance sheet independence to measure how much of total assets are equity-financed.
CARL ZEISS MEDITEC ADR 1 Cash Flow Quality Index by Year (2022–2025)
CARL ZEISS MEDITEC ADR 1 cash flow quality index by year from 2022 to 2025. Year-by-year earnings quality comparison for CARL ZEISS MEDITEC ADR 1. For the full cash flow conversion analysis, see AFXA operating cash flow.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.49x | €209.86 Million | €141.21 Million | ▲ +7.4% |
| 2024 | 1.38x | €247.32 Million | €178.73 Million | ▲ +60.2% |
| 2023 | 0.86x | €250.86 Million | €290.40 Million | ▲ +34.9% |
| 2022 | 0.64x | €188.20 Million | €293.91 Million | — |